Wells Fargo’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Wells Fargo’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$4K	–	6646
2016 Q3	$4K	Hold	1,000	–	–	﹤0.01%	5980
2016 Q2	$5K	Hold	1,000	–	–	﹤0.01%	5832
2016 Q1	$5K	Hold	1,000	–	–	﹤0.01%	5886
2015 Q4	$5K	Hold	1,000	–	–	﹤0.01%	5894
2015 Q3	$4K	Hold	1,000	–	–	﹤0.01%	5918
2015 Q2	$9K	Hold	1,000	–	–	﹤0.01%	5860
2015 Q1	$9K	Hold	1,000	–	–	﹤0.01%	5679
2014 Q4	$14K	Buy	+1,000	New	+$14.5K	﹤0.01%	5510

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wells Fargo's CPHR Position: Q4 2016 in Review

Wells Fargo sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 1,000 shares — an estimated $4K sold.

Wells Fargo first reported a position in CPHR in Q4 2014 and held it in 8 quarters. The position peaked at $14K in Q4 2014. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Wells Fargo reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Wells Fargo sold 1,000 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $4K.
Wells Fargo first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
Wells Fargo's Cipher Pharmaceuticals Inc. position peaked at $14K in Q4 2014.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Wells Fargo's 13F filing for Q4 2016, filed 1 Feb 2017.